WEKO3
アイテム
Stress in Children with Pervasive Developmental Disorders
https://dmu.repo.nii.ac.jp/records/977
https://dmu.repo.nii.ac.jp/records/977b9b7e37d-1e80-4d1c-b6d9-d776f74e599c
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
KJ00007523020.pdf (99.3 kB)
|
|
| Item type | [ELS]学術雑誌論文 / Journal Article(1) | |||||||
|---|---|---|---|---|---|---|---|---|
| 公開日 | 2017-05-24 | |||||||
| タイトル | ||||||||
| タイトル | Stress in Children with Pervasive Developmental Disorders | |||||||
| 言語 | en | |||||||
| 言語 | ||||||||
| 言語 | eng | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題 | pervasive developmental disorders | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題 | mental retardation | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題 | stress | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題 | 17-hydroxycorticosteroids | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題 | children | |||||||
| 資源タイプ | ||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||
| 資源タイプ | journal article | |||||||
| 雑誌書誌ID | ||||||||
| 収録物識別子 | AA00629581 | |||||||
| 論文名よみ | ||||||||
| タイトル | Stress in Children with Pervasive Developmental Disorders | |||||||
| 著者 |
Suzuki, Naomitsu
× Suzuki, Naomitsu
|
|||||||
| 著者所属(英) | ||||||||
| en | ||||||||
| Department of Pediatrics, Dokkyo Medical University School of Medicine | ||||||||
| 記事種別(英) | ||||||||
| 内容記述タイプ | Other | |||||||
| 内容記述 | Original | |||||||
| 抄録(英) | ||||||||
| 内容記述タイプ | Other | |||||||
| 内容記述 | The purpose of this study is to examine urinary 17-hydroxycorticosteroid (OHCS) excretion as a measureof stress response in controls and in children with pervasive developmental disorders (PDDs) accompaniedby mental retardation( MR, intelligence quotient[ IQ]<70)( low-functioning PDD:LFPDD) or notaccompanied by MR( IQ≧70)( high-functioning PDD:HFPDD). Prospective, non-randomized study of 24children with LFPDD ─ 17 with autism and seven with PDDs not otherwise specified( PDDs-NOS) ─ and14 children with HFPDD ─ 11 with PDDs-NOS and three with Asperger's disorders. Urinary 17-OHCSwas measured between June 2002 and June 2004. In 21 of 24 LFPDD subjects and 8 of 14 HFPDD subjectsa second measurement was taken 6 to 12-months after the first, after the subjects had received interventionfor developmental disorders. Baseline urinary 17-OHCS levels in both LFPDD( p<0.0005) and HFPDD(p<0.005) were significantly higher than in controls. LFPDD subjects had significantly greater (p<0.05)levels of this stress hormone than did HFPDD subjects. Levels of 17-OHCS in both LFPDD (p<0.05) andHFPDD (p<0.05) decreased significantly after 6 to 12 months of intervention. PDD subjects showed higherlevels of 17-OHCS than controls and showed a significant reduction in the level of stress indicator after theyhad received intervention for developmental disorders. | |||||||
| 書誌情報 |
Dokkyo journal of medical sciences 巻 38, 号 3, p. 207-213, 発行日 2011-10-25 |
|||||||
| ISSN | ||||||||
| 収録物識別子タイプ | ISSN | |||||||
| 収録物識別子 | 03855023 | |||||||
